semaglutide with tirzepatide vs. Tirzepatide: What's the Difference and Which Is Right for You?: Envizion Medical: Wellness Center Medical Weight Loss - Your

As a glucagon-like peptide-1 (GLP-1) receptor agonist, Wegovy mimics the GLP-1 hormone in the body and, in doing so, suppresses appetite and slows gastric (stomach) emptying

The analysis included data from 18,742 patients with type 2 diabetes mellitus (T2DM) receiving 5.0mg, 10.0mg, or 15.0mg once-weekly subcutaneous tirzepatide or 0.5mg, 1.0mg, or 2.0mg once-weekly subcutaneous semaglutide for at least 12 weeks

Build real, physician-led protocols

You will administer 1-2mL/cc twice weekly, or as prescribed

A 2024 study of eight women using GLP-1 medications showed no evidence of transfer into breast milk

doi:10.1097/JCN.0000000000000469